MENU
PULM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Pulmatrix (PULM) Ownership - Who owns Pulmatrix?
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
36 Crosby Drive
Phone
+1 781 357-2333
Employees
22
Web
https://www.pulmatrix.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
28.52M
P/E Ratio
N/A
Total Cash
7.71M
Projected Growth
N/A
Total Debt
N/A
Revenue
1.92M
Risk (Beta)
2.11
Dividend Yield
N/A
Total Cash/Share
2.11
Total Debt/Equity
N/A
Revenue/Share
0.53 USD as % of share price
Fundamentals
PULM
Capitalization
28.5M
P/E Ratio
N/A
Risk (Beta)
2.11
Dividend Yield
N/A
Total Cash
7.71M
Total Cash/Share
2.11
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.53%
Revenue
1.92M
ROE
N/A
Book Value
7.15M
P/B Ratio
3.99
Cash Flow
N/A
Earnings
-3.35
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
8.90
Current Revenue Per Employee
16636.36
Dividends Per Share - Security
N/A
EBITDA
-9.58M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-63.43
Shares Held By Institutions
2.5M
Shares Outstanding - Current
3.65M
Total Liabilities
904K
Total Volume MTD
N/A
Value
N/A
Gain YTD
11.891
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceuticals for pulmonary disease
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
36 Crosby Drive
Phone
+1 781 357-2333
Employees
22
Web
https://www.pulmatrix.com